Insider holders · CIK 0001819790
Tarsus Pharmaceuticals, Inc. · TARS
Every insider with a reported Table I holding at this company, ranked by their last-reported share count. A balance is only as fresh as its filing — the report date sits next to every row on purpose. ← Back to activity
| Insider | Direct shares | Indirect shares | Total reported | Last report (ET) | From |
|---|---|---|---|---|---|
| Bobak R. AzamianPresident/CEO and Board Chair | 33,421 | 827,991 | 861,412 | Sep 9, 2026 · 4:14 pm EDT | Form 4 |
| William J Link Ph.D.Director | 94,487 | — | 94,487 | Sep 17, 2026 · 4:22 pm EDT | Form 4 |
| Seshadri NeervannanChief Operating Officer | 78,532 | 475 | 79,007 | Sep 9, 2026 · 4:12 pm EDT | Form 4 |
| Jeffrey S FarrowSee Remarks | 56,801 | — | 56,801 | Jun 17, 2026 · 4:17 pm EDT | Form 4 |
| Andrew D. GoldbergDirector | 19,654 | — | 19,654 | Jun 16, 2026 · 4:05 pm EDT | Form 4 |
| Wendy L YarnoDirector | 16,956 | — | 16,956 | Sep 17, 2026 · 4:22 pm EDT | Form 4 |
| Elizabeth Yeu LinChief Medical Officer | 2,547 | 12,040 | 14,587 | Sep 9, 2026 · 4:13 pm EDT | Form 4 |
| Scott W MorrisonDirector | 7,638 | 6,016 | 13,654 | Jun 16, 2026 · 4:06 pm EDT | Form 4 |
| Bhaskar ChaudhuriDirector | 11,654 | — | 11,654 | Jun 16, 2026 · 4:06 pm EDT | Form 4 |
| David E I PyottDirector | — | 9,575 | 9,575 | Sep 17, 2026 · 4:47 pm EDT | Form 4 |
| Katherine GoodrichDirector | 2,233 | — | 2,233 | Jun 17, 2026 · 4:17 pm EDT | Form 4 |
Balances come from each insider’s most recent filing that reports a Table I holding; an insider who left the company years ago still appears with their last-known figure and its date. Indirect totals collapse multiple vehicles (trusts, LLCs) into one number — open the filing for the breakdown. Shares as filed, not split-adjusted.